Clinitech Laboratory P/E Ratio
Current P/E Ratio
23.35
Moderate Valuation
High - Growth expectations or overvalued
Clinitech Laboratory (CTLLAB) P/E ratio is 23.35 (Moderate), EPS (TTM) ₹1.90, current price ₹ on None — High - Growth expectations or overvalued. Analyse CTLLAB FII DII holdings to track promoter, FII and institutional holdings.
Current Valuation Metrics
P/E Ratio
23.35
Current Price
₹
EPS (TTM)
₹1.90
Exchange
None
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
68.28
Sector Median
45.42
Sector Rank
#11 of 56
Sector Percentile
19.6%
CTLLAB P/E Ratio — Valuation Signal & Historical Context
Clinitech Laboratory P/E 23.35 — signal: Overvalued. For live price, revenue and the complete fundamental profile, see Clinitech Laboratory share price today.
- Trading at discount to sector average PE of 68.28
CTLLAB vs Healthcare Services Peers — P/E Ratio Comparison
Clinitech Laboratory P/E 23.35 vs Healthcare Services average 68.28, median 45.42 — range 7.98–460.81.
Sector Average
68.28
Sector Median
45.42
Lowest P/E
7.98
Highest P/E
460.81
Companies
56
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Star Imaging And Path Lab | STARIMAGIN | 7.98 | ₹125 | Low |
| Shanmuga Hospital | SHANMUGA | 12.91 | ₹54 | Low |
| Nidan Labs & Healthcare | NIDAN | 13.47 | ₹20 | Low |
| Deccan Health Care | DECCAN | 14.18 | ₹32 | Low |
| One Global Service Provi… | ONEGLOBAL | 14.84 | ₹920 | Low |
| Abate AS Industries | ABATEAS | 14.93 | ₹162 | Low |
| Invicta Diagnostic | INVICTA | 17.24 | ₹80 | Moderate |
| 3B BlackBio DX | 3BBLACKBIO | 17.7 | ₹1,061 | Moderate |
| Indraprastha Medical Cor… | INDRAMEDCO | 17.93 | ₹3,334 | Moderate |
| Dr Lalchandani Labs | DLCL | 19.85 | ₹8 | Moderate |